Currently, there are 188.63M common shares owned by the public and among those 176.46M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -18.77% and -7.90% over the past three months. BFLY shares are trading -2.88% year to date (YTD), with the 12-month market performance up to 154.62% higher. It has a 12-month low price of $0.67 and touched a high of $4.98 over the same period. BFLY has an average intraday trading volume of 4.32 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -27.15%, -21.28%, and 37.57% respectively.
Institutional ownership of Butterfly Network Inc (NYSE: BFLY) shares accounts for 25.85% of the company’s 188.63M shares outstanding.
It has a market capitalization of $736.06M and a beta (3y monthly) value of 2.51. The earnings-per-share (ttm) stands at -$0.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 17.83% over the week and 11.26% over the month.
Earnings per share for the fiscal year are expected to decrease by -31.75%, and 12.05% over the next financial year. EPS should shrink at an annualized rate of -5.98% over the next five years, compared to 66.40% over the past 5-year period.
Looking at the support for the BFLY, a number of firms have released research notes about the stock. Lake Street stated their Buy rating for the stock in a research note on September 10, 2024, with the firm’s price target at $3. UBS coverage for the Butterfly Network Inc (BFLY) stock in a research note released on March 29, 2023 offered a Neutral rating with a price target of $2.25. Oppenheimer was of a view on November 29, 2022 that the stock is Outperform, while B. Riley Securities gave the stock Buy rating on October 04, 2022, issuing a price target of $9.50. UBS on their part issued Neutral rating on December 17, 2021.
